lepirudin
Selected indexed studies
- Lepirudin. (, 2006) [PMID:30000058]
- Lepirudin in the management of heparin-induced thrombocytopenia. (Expert Opin Drug Metab Toxicol, 2008) [PMID:18680447]
- Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. (J Thromb Haemost, 2005) [PMID:16241940]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Lepirudin. (2006) pubmed
- Lepirudin in the management of heparin-induced thrombocytopenia. (2008) pubmed
- Lepirudin in patients with heparin-induced thrombocytopenia - results of the third prospective study (HAT-3) and a combined analysis of HAT-1, HAT-2, and HAT-3. (2005) pubmed
- Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy. (2004) pubmed
- Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis. (2017) pubmed
- Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis. (2002) pubmed
- Heparin-induced thrombocytopenia with thromboembolic complications: meta-analysis of 2 prospective trials to assess the value of parenteral treatment with lepirudin and its therapeutic aPTT range. (2000) pubmed
- Lepirudin blunts endotoxin-induced coagulation activation. (2000) pubmed
- Lepirudin: a review of its potential place in the management of thrombotic disorders. (1998) pubmed
- Recombinant hirudin in clinical practice: focus on lepirudin. (2001) pubmed